Unknown

Dataset Information

0

An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line.


ABSTRACT: Drug resistance in lymphoblastic and myeloblastic leukemia cells is poorly understood, with several lines of evidence suggesting that resistance can be correlated with upregulation of human asparagine synthetase (hASNS) expression, although this hypothesis is controversial. New tools are needed to investigate this clinically important question, including potent hASNS inhibitors. In vitro experiments show an adenylated sulfoximine to be a slow-onset, tight-binding inhibitor of hASNS with nanomolar affinity. This binding affinity represents a 10-fold improvement over that reported for the only other well-characterized hASNS inhibitor. The adenylated sulfoximine has a cytostatic effect on L-asparaginase-resistant MOLT-4 cells cultured in the presence of L-asparaginase, an enzyme that depletes L-asparagine in the growth medium. These observations represent direct evidence that potent hASNS inhibitors may prove to be effective agents for the clinical treatment of acute lymphoblastic leukemia.

SUBMITTER: Gutierrez JA 

PROVIDER: S-EPMC3608209 | biostudies-literature | 2006 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line.

Gutierrez Jemy A JA   Pan Yuan-Xiang YX   Koroniak Lukasz L   Hiratake Jun J   Kilberg Michael S MS   Richards Nigel G J NG  

Chemistry & biology 20061201 12


Drug resistance in lymphoblastic and myeloblastic leukemia cells is poorly understood, with several lines of evidence suggesting that resistance can be correlated with upregulation of human asparagine synthetase (hASNS) expression, although this hypothesis is controversial. New tools are needed to investigate this clinically important question, including potent hASNS inhibitors. In vitro experiments show an adenylated sulfoximine to be a slow-onset, tight-binding inhibitor of hASNS with nanomola  ...[more]

Similar Datasets

| S-EPMC1222032 | biostudies-other
| S-EPMC8441542 | biostudies-literature
| S-EPMC6962308 | biostudies-literature
| S-EPMC7219601 | biostudies-literature
| S-EPMC4123961 | biostudies-literature
| S-EPMC6748925 | biostudies-literature
| S-EPMC1221958 | biostudies-other
| S-EPMC6310878 | biostudies-literature
| S-EPMC7818274 | biostudies-literature
| S-EPMC9478401 | biostudies-literature